Risperdal Victim Asks Pa. Judge For New Damages Trial

Law360, New York (December 18, 2015, 8:36 PM EST) -- After winning a $500,000 verdict against a Johnson & Johnson unit last week when a Philadelphia jury found the antipsychotic drug Risperdal had hidden risks and caused a male patient to grow breasts, the Wisconsin man on Friday asked a judge for a new trial on damages.

Timothy Stange, who secured a favorable jury verdict on Dec. 11 in his case against Janssen Pharmaceuticals Inc., said in a post-trial motion that as a result of judicial error in pretrial orders and the judge's refusal to give requested jury instructions, he was unfairly prevented from pursuing a claim for punitive damages at...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!